Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Other financing activities (2020 - 2026)

Alx Oncology Holdings' Other financing activities history spans 4 years, with the latest figure at $112000.0 for Q2 2023.

  • On a quarterly basis, Other financing activities fell 27.74% to $112000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $494000.0, a 64.79% decrease, with the full-year FY2025 number at $14000.0, down 99.14% from a year prior.
  • Other financing activities hit $112000.0 in Q2 2023 for Alx Oncology Holdings, down from $222000.0 in the prior quarter.
  • Over the last five years, Other financing activities for ALXO hit a ceiling of $12.5 million in Q4 2020 and a floor of $5000.0 in Q3 2022.
  • Historically, Other financing activities has averaged $1.5 million across 4 years, with a median of $299000.0 in 2020.
  • Biggest five-year swings in Other financing activities: surged 78.26% in 2021 and later tumbled 99.06% in 2022.
  • Tracing ALXO's Other financing activities over 4 years: stood at $12.5 million in 2020, then plummeted by 95.76% to $530000.0 in 2021, then tumbled by 58.11% to $222000.0 in 2022, then crashed by 49.55% to $112000.0 in 2023.
  • Business Quant data shows Other financing activities for ALXO at $112000.0 in Q2 2023, $222000.0 in Q4 2022, and $5000.0 in Q3 2022.